Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.28%
1,085.81
+3.01
+0.28%
1,082.801,079.311,090.181,079.31
SIXC
Communications
SIXC
Communications
SIXC
+0.65%
607.69
+3.92
+0.65%
603.77603.77611.65602.09
SIXE
Energy
SIXE
Energy
SIXE
-1.55%
1,192.38
-18.81
-1.55%
1,211.191,203.051,203.481,182.72
SIXI
Industrials
SIXI
Industrials
SIXI
+0.02%
1,756.39
+0.40
+0.02%
1,755.991,759.061,761.741,747.23
SIXM
Financials
SIXM
Financials
SIXM
-0.82%
633.27
-5.24
-0.82%
638.51637.93640.10631.89
SIXR
Staples
SIXR
Staples
SIXR
+1.12%
852.42
+9.46
+1.12%
842.96843.54858.44843.54
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.22%
218.79
-0.49
-0.22%
219.28219.28220.58218.64
SIXT
Technology
SIXT
Technology
SIXT
-0.45%
3,711.69
-16.66
-0.45%
3,728.353,745.063,745.063,675.02
SIXU
Utilities
SIXU
Utilities
SIXU
-0.48%
911.05
-4.43
-0.48%
915.48914.49915.84907.90
SIXV
Health care
SIXV
Health care
SIXV
+0.22%
1,500.66
+3.30
+0.22%
1,497.361,500.651,514.701,495.89
SIXY
Discretionary
SIXY
Discretionary
SIXY
+1.73%
2,454.96
+41.79
+1.73%
2,413.172,431.692,463.522,431.69
SIGA:NASDAQ
SIGA Technologies Inc
$4.73
+1.28%
(+0.060) 1D
$4.73
0.00% (0.00)
After hours
Closed: May 27, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SIGA...
Open
$4.68
High
$4.76
Low
$4.68
Mkt. cap
339.25M
Avg. vol.
512.60K
Volume
281.15K
P/E ratio
16.80
52-wk high
$9.62
52-wk low
$4.10
EPS
$0.28
Beta
0.92
Shares outstanding
71.72M
No. of employees
49
News stories
From sources across the web
Profile
SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications. Wikipedia
About SIGA Technologies Inc
CEODiem Nguyen
Employees49
FoundedDec 28, 1995
Headquarters-
SectorPharmaceutical industry
Websitesiga.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
81.12M
2.62M
3.79M
6.24M
Cost of goods sold
29.95M
8.06M
8.03M
6.89M
Cost of revenue
29.95M
8.06M
8.03M
6.89M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.49M
4.79M
5.26M
4.67M
Operating expense
5.49M
4.79M
5.26M
4.67M
Total operating expenses
35.44M
12.84M
13.29M
11.56M
Operating income
45.68M
-10.22M
-9.50M
-5.32M
Other non operating income
-
-
-
-
EBT including unusual items
47.27M
-8.36M
-7.96M
-4.04M
EBT excluding unusual items
47.27M
-8.36M
-7.96M
-4.04M
Income tax expense
11.79M
-1.99M
-2.53M
-589.43K
Effective tax rate
24.94%
23.82%
31.82%
14.58%
Other operating expenses
-
-
-
-
Net income
35.48M
-6.37M
-5.43M
-3.45M
Net profit margin
43.74%
-242.97%
-143.12%
-55.33%
Earnings per share
-
-
-
-
Interest and investment income
1.59M
1.87M
1.54M
1.28M
Interest expense
-
-
-
-
Net interest expenses
1.59M
1.87M
1.54M
1.28M
Depreciation and amortization charges
-
-
-
-
EBITDA
45.82M
-10.08M
-9.35M
-5.17M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more